Breast Reconstruction Market Size & Growth | Forecast to 2028
The breast reconstruction market is expected to reach US$ 945.27 million by 2028 from US$ 593.61 million in 2020; it is estimated to grow at a CAGR of 6.1% during 2021–2028.
Breast reconstruction is the surgical process of rebuilding the shape and look of a breast, most commonly in women who have had surgery as a part of breast cancer treatment. To reconstruct a natural-looking breast, the reconstruction process is done by using autologous tissue, prosthetic implants, or a combination of both .
The growth of the breast reconstruction market is attributed to the factors such as the high prevalence of breast cancer, and new product launches and FDA approvals. However, low awareness regarding reimbursement policies hinders the market growth.
Market Insights
High Prevalence of Breast Cancer
Breast cancer is one of the most common types of cancer observed among women. It is majorly characterized by the development of lumps in breasts, inversion of nipples, change in breast shape, release of fluids from nipples, red or scaly patches on skin, dimpling of the skin, and pain and soaring of nipples. Breast cancer is treated using mastectomy, a procedure that includes removal of entire breast through a surgical process. Breast reconstruction surgeries are used to rebuild the breasts after mastectomy. Implant reconstruction and autologous or flap reconstruction are the two main techniques used in these surgeries. With the increasing prevalence of breast cancer worldwide, many women are opting for reconstruction procedures to regain the original shape of their breasts after the mastectomy. According to breastcancer.org, as of January 2018, over 3.1 million women in the US had a history of breast cancer, including those who were undergoing a treatment and those who had undergone treatments in the past. Further, according to a study published by the World Health Organization (WHO), ~2.3 million women across the world were newly diagnosed with breast cancer in 2020. In addition, according to a study published in the journal of American Society of Clinical Oncology in 2020, ~1 in 29 women in India suffers from breast cancer at some point in life. Similarly, according to the breastcancercare.org.uk, the UK had ~691,000 women diagnosed with breast cancer and this number is estimated to reach 840,000 by 2020. Similar trends of rise in number of breast cancer cases have been observed in other parts of the world. The increasing prevalence of breast cancer, coupled with the growing preference for breast reconstruction procedures post mastectomy, is bolstering the market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Breast Reconstruction Market: Strategic Insights
Breast Reconstruction Market
-
CAGR (2020 - 2028)
6.1%
-
Market Size 2020
US$ 593.61 Million
-
Market Size 2028
US$ 945.27 Million
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Allergan Plc
- Mentor Worldwide LLC Subsidiary of Johnson Johnson
- Sientra Inc
- GC Aesthetics PLC
- POLYTECH Health Aesthetics GmbH
- HANSBIOMED CO LTD
- IDEAL IMPLANT INCORPORATED
- Guangzhou Wanhe Plastic Materials Co Ltd
- Establishment Labs S A
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Technology
- Inframammary
- Peri-Areolar
- Trans-Axillary
- Transumbilical
Type
- Breast Implants
- Implant Accessories
Placement
- Dual-Plane Insertion
- Subglandular Insertion
- Submuscular Insertion
Procedure
- Immediate Procedures
- Delayed Procedures
- Revision Procedures
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Breast Reconstruction Market: Strategic Insights
-
CAGR (2020 - 2028)6.1% -
Market Size 2020
US$ 593.61 Million -
Market Size 2028
US$ 945.27 Million
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Allergan Plc
- Mentor Worldwide LLC Subsidiary of Johnson Johnson
- Sientra Inc
- GC Aesthetics PLC
- POLYTECH Health Aesthetics GmbH
- HANSBIOMED CO LTD
- IDEAL IMPLANT INCORPORATED
- Guangzhou Wanhe Plastic Materials Co Ltd
- Establishment Labs S A
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
- Inframammary
- Peri-Areolar
- Trans-Axillary
- Transumbilical
- Breast Implants
- Implant Accessories
- Dual-Plane Insertion
- Subglandular Insertion
- Submuscular Insertion
- Immediate Procedures
- Delayed Procedures
- Revision Procedures
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Technology -Based Insights
The breast reconstruction market, by technology, is segmented into inframammary, peri-areolar, trans-axillary, and transumbilical. The inframammary segment held the largest share of the market in 2020, and the peri-areolar segment is anticipated to register the highest CAGR in the market during the forecast period.
Type-based Insights
By type, the breast reconstruction market is bifurcated into breast implants and implants accessories. The breast implants segment held a larger share of the market in 2020, and the same segment is anticipated to register a higher CAGR in the market during the forecast period.
Placement -based Insights
By Placement, the breast reconstruction market is segmented into dual-plane insertion, subglandular insertion, and submuscular insertion. The dual plane insertion segment held the largest share of the market in 2020. Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.
Procedure -based Insights
By Procedure, the breast reconstruction market is segmented into immediate procedures, delayed procedures, and revision procedures. In 2020, the immediate procedures segment held the largest share of the market. Also, the market for the same segment is expected to grow at the fastest rate during the coming years.
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the breast reconstruction market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.
Breast Reconstruction Market Report Scope
Report Attribute
Details
Market size in 2020
US$ 593.61 Million
Market Size by 2028
US$ 945.27 Million
Global CAGR (2020 - 2028)
6.1%
Historical Data
2018-2019
Forecast period
2021-2028
Segments Covered
By Technology - Inframammary
- Peri-Areolar
- Trans-Axillary
- Transumbilical
By Type - Breast Implants
- Implant Accessories
By Placement - Dual-Plane Insertion
- Subglandular Insertion
- Submuscular Insertion
By Procedure - Immediate Procedures
- Delayed Procedures
- Revision Procedures
Regions and Countries Covered
North America - US
- Canada
- Mexico
Europe - UK
- Germany
- France
- Russia
- Italy
- Rest of Europe
Asia-Pacific - China
- India
- Japan
- Australia
- Rest of Asia-Pacific
South and Central America - Brazil
- Argentina
- Rest of South and Central America
Middle East and Africa - South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
Market leaders and key company profiles
- Allergan Plc
- Mentor Worldwide LLC Subsidiary of Johnson Johnson
- Sientra Inc
- GC Aesthetics PLC
- POLYTECH Health Aesthetics GmbH
- HANSBIOMED CO LTD
- IDEAL IMPLANT INCORPORATED
- Guangzhou Wanhe Plastic Materials Co Ltd
- Establishment Labs S A
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Attribute | Details |
---|---|
Market size in 2020 | US$ 593.61 Million |
Market Size by 2028 | US$ 945.27 Million |
Global CAGR (2020 - 2028) | 6.1% |
Historical Data | 2018-2019 |
Forecast period | 2021-2028 |
Segments Covered |
By Technology
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
By Technology
- Inframammary
- Peri-Areolar
- Trans-Axillary
- Transumbilical
By Type
- Breast Implants
- Implants accessories
By Placement
- Dual Plane Insertion
- Subglandular Insertion
- Submuscular Insertion
By Procedure
- Immediate Procedures
- Delayed Procedures
- Revision Procedures
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Allergan Plc
- Mentor Worldwide LLC (Subsidiary of Johnson & Johnson)
- Sientra Inc.
- GC Aesthetics PLC
- POLYTECH Health & Aesthetics GmbH
- HANSBIOMED CO. LTD
- IDEAL IMPLANT INCORPORATED
- Guangzhou Wanhe Plastic Materials Co., Ltd.
- Establishment Labs S.A.
- Groupe Sebbin SAS
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology , Type ; Placement , Procedure , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The growth of the region is attributed to factors such as increasing incidence of breast cancer and favorable reimbursement policies. Moreover, presence of well-developed healthcare infrastructure and government support are some of the prominent factors propelling the market growth in North America. In addition, the Asia Pacific is expected account for the fastest growth in the breast reconstruction market. An increasing awareness about breast reconstruction therapies through government support coupled with increasing investments for product development, sales and distributions is anticipated to offer lucrative opportunities for the growth of Asia Pacific breast reconstruction market during the forecast period.
Breast reconstruction is the surgical process of rebuilding the shape and look of a breast, most commonly in women who have had surgery to treat breast cancer. It involves using autologous tissue, prosthetic implants, or a combination of both with the goal of reconstructing a natural-looking breast.
The growth of the market is attributed to some key driving factors such as attributed to increasing product development and growing government support for breast reconstruction procedures. In addition, the growing incidence of breast cancer is also offering a favorable growth opportunity. For instance, according to a study published on NCBI in 2020, for implant-based reconstructions the average reimbursement was around 16.3% for Medicaid and around 67.2% for private insurance. Such strategic steps are also projected to drive the market growth.
The List of Companies - Global Breast Reconstruction Market
- Allergan Plc
- Mentor Worldwide LLC ( Subsidiary of Johnson & Johnson)
- Sientra Inc.
- GC Aesthetics PLC
- POLYTECH Health & Aesthetics GmbH
- HANSBIOMED CO. LTD
- IDEAL IMPLANT INCORPORATED
- Guangzhou Wanhe Plastic Materials Co., Ltd.
- Establishment Labs S.A.
- Groupe Sebbin SAS